Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001319971 | SCV001510738 | uncertain significance | Congenital myasthenic syndrome 4A | 2021-10-25 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine with threonine at codon 365 of the CHRNE protein (p.Ala365Thr). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and threonine. This variant is present in population databases (rs780327519, ExAC 0.006%). This variant has not been reported in the literature in individuals affected with CHRNE-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CHRNE protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001835602 | SCV002093391 | uncertain significance | Congenital myasthenic syndrome | 2020-01-17 | no assertion criteria provided | clinical testing |